- Country: USA
- Summary: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration
- UST Ref No: 114185779
- Deadline: 07 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: SPE2DP-25-R-0001
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Defense Logistics Agency - Troop Support Medical Supply Chain (DLA-Troop Support) is seeking sources capable of providing the Adenovirus Vaccine. The vaccine shall be live, bivalent, enteric-coated tablets, intended for active immunization for the prevention of respiratory infections caused by the Adenovirus types 4 and 7, suitable for oral administration only. A package (PG) consists of two (2) bottles - one (1) bottle of 100 tablets each of Adenovirus Type 4 and one (1) bottle of 100 tablets each of Adenovirus Type 7. Additionally, one (1) dose shall constitute two (2) tablets - one (1) tablet each of Adenovirus Type 4 and Adenovirus Type 7, or 100 doses per PG. Product shall be FDA approved.
DLA-Troop Support is contemplating awarding an Indefinite Delivery-Indefinite Quantity (IDIQ) contract for the Adenovirus Vaccine with a one-year base period and four (4) one-year option periods. The estimated annual quantity to be ordered is 2,000 Packages (200,000 doses/ 400,000 tablets). The anticipated annual guaranteed minimum purchase quantity is estimated to be 1,500 PG (150,000 doses/300,000 tablets), and the anticipated annual maximum is estimated to be 2,300 PG (230,000 doses/460,000 tablets). The quantities indicated above are estimates only. The quantity may increase or decrease considerably as the requirements are subject to change as the Services requirements change.
The successful offeror shall have Federal Drug Administration (FDA) approval to supply the requisite Adenovirus vaccine prior to contract award. Ordered quantities shall be delivered to various military activities throughout the United States. Delivery is scheduled on a monthly basis to these activities. First deliveries shall begin 3-6 months after contract award, or best available delivery negotiated between the contractor and the government.
THERE IS NO SOLICITATION AT THIS TIME. This is a request for information (RFI) and does not commit the U.S. Government to iss... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAdenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration - USA Tender
The DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY, a Government sector organization in USA, has announced a new tender for Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration. This tender is published on USARFP under UST Ref No: 114185779 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
